Caris Life Sciences, Inc. financial data

Symbol
CAI on Nasdaq
Location
Irving, TX
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 282,579,919 shares
Common Stock, Shares, Outstanding 282,526,097 shares 674%
Entity Public Float $3,870,000,000 USD
Common Stock, Value, Issued $283,000 USD 645%
Weighted Average Number of Shares Outstanding, Basic 282,099,073 shares 691%
Weighted Average Number of Shares Outstanding, Diluted 297,211,838 shares 734%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $216,833,000 USD 113%
Research and Development Expense $21,624,000 USD -22%
Selling and Marketing Expense $41,267,000 USD 12%
General and Administrative Expense $51,973,000 USD 27%
Costs and Expenses $184,191,000 USD 13%
Operating Income (Loss) $32,642,000 USD
Nonoperating Income (Expense) $8,317,000 USD -21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24,325,000 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $24,325,000 USD
Earnings Per Share, Basic 0.09 USD/shares
Earnings Per Share, Diluted 0.08 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $796,274,000 USD 1145%
Marketable Securities, Current $2,295,000 USD 4.3%
Accounts Receivable, after Allowance for Credit Loss, Current $112,140,000 USD 27%
Other Assets, Current $2,355,000 USD -65%
Assets, Current $997,800,000 USD 363%
Property, Plant and Equipment, Net $63,170,000 USD -6.9%
Operating Lease, Right-of-Use Asset $39,848,000 USD 14%
Goodwill $19,344,000 USD 0%
Other Assets, Noncurrent $45,349,000 USD 11%
Assets $1,125,663,000 USD 227%
Accounts Payable, Current $39,206,000 USD 41%
Accrued Liabilities, Current $87,770,000 USD 13%
Contract with Customer, Liability, Current $24,492,000 USD 228%
Liabilities, Current $127,145,000 USD -23%
Operating Lease, Liability, Noncurrent $42,335,000 USD 9.5%
Other Liabilities, Noncurrent $42,388,000 USD -4.6%
Liabilities $548,356,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $936,000 USD 346%
Retained Earnings (Accumulated Deficit) $2,548,736,000 USD -3.1%
Stockholders' Equity Attributable to Parent $577,307,000 USD
Liabilities and Equity $1,125,663,000 USD 227%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2,800,000,000 shares 143%
Common Stock, Shares, Issued 284,137,810 shares 674%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $800,042,000 USD 1076%
Deferred Tax Assets, Valuation Allowance $410,409,000 USD -2.6%
Deferred Tax Assets, Gross $424,321,000 USD -2.3%
Operating Lease, Liability $48,694,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $24,404,000 USD
Lessee, Operating Lease, Liability, to be Paid $72,395,000 USD
Property, Plant and Equipment, Gross $304,150,000 USD 2.6%
Operating Lease, Liability, Current $6,359,000 USD 4.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,267,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $11,333,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.113 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $23,701,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $9,203,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $309,547,000 USD 6.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,588,000 USD
Additional Paid in Capital $3,141,720,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $4,900,000 USD -53%
Share-based Payment Arrangement, Expense $13,655,000 USD 189%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%